XML 20 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 148,813 $ 245,197
Investments in marketable securities 144,782 237,299
Accounts receivable 66,196 52,672
Inventories 23,816 26,818
Prepaid expenses and other current assets 40,209 34,848
Total current assets 423,816 596,834
Operating lease right-of-use assets, net 29,534 20,586
Property and equipment, less accumulated depreciation of $22,281 and $19,882 at December 31, 2022 and 2021, respectively 30,778 42,496
In-process research & development 23,000 23,000
Goodwill 197,797 197,797
Other non-current assets 19,242 24,427
Total Assets 724,167 905,140
Current liabilities:    
Accounts payable 15,413 21,513
Accrued expenses and other current liabilities 93,636 98,153
Contingent consideration payable 21,417 18,900
Operating lease liabilities 8,552 7,409
Total current liabilities 139,018 145,975
Long-term debt 391,990 389,357
Operating lease liabilities 51,578 43,363
Deferred income taxes 4,939 4,930
Deferred reimbursements 4,656 5,906
Other non-current liabilities 8,939 8,240
Total liabilities 601,120 597,771
Commitments and contingencies
Stockholders' equity:    
Common stock, $0.01 par value, 500,000,000 shares authorized, 281,108,273 and 278,912,800 shares issued and outstanding at December 31, 2022 and 2021, respectively 2,815 2,808
Additional paid-in capital 2,664,744 2,595,419
Accumulated other comprehensive (loss) gain:    
Foreign currency translation adjustment (11,989) 5,251
Unrealized loss on available-for-sale securities (116) (270)
Warrants 83 83
Accumulated deficit (2,532,490) (2,295,922)
Total stockholders' equity 123,047 307,369
Total Liabilities and Stockholders' Equity $ 724,167 $ 905,140